LMR Partners’s Fulgent Genetics FLGT Stock Holding History

LMR Partners’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,141	Closed	-$64K	–	397
2017 Q2	$64K	Buy	+10,141	New	+$81.8K	﹤0.01%	579

Other funds holding FLGT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Scholtz & Company Stamford, Connecticut $195M AUM 12.04% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LMR Partners's FLGT Position: Q3 2017 in Review

LMR Partners sold out of Fulgent Genetics (FLGT) in Q3 2017, closing a stake of 10,141 shares — an estimated $64K sold.

LMR Partners first reported a position in FLGT in Q2 2017 and held it in 1 quarter. The position peaked at $64K in Q2 2017. 21 funds tracked by Wall St. Rank hold FLGT as of Q3 2017.

LMR Partners reported no remaining Fulgent Genetics position as of Q3 2017 after selling out during the quarter.
LMR Partners sold 10,141 Fulgent Genetics shares in Q3 2017, an estimated $64K.
LMR Partners first reported a position in Fulgent Genetics in Q2 2017 and held it in 1 quarter.
LMR Partners's Fulgent Genetics position peaked at $64K in Q2 2017.
21 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2017.

Based on LMR Partners's 13F filing for Q3 2017, filed 9 Nov 2017.